Product
Supplier
Encyclopedia
Inquiry
Sancycline buy - large image1
Sancycline buy - image1
Sancycline buy - image2

Sancycline

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

808-26-4

Grade:

Pharmaceutical Grade

Packaging:

25kg drum

Price valid (until):

2024-08-07

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Sancycline is a rare semi-synthetic tetracycline prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of declomycin, first reported in 1962.

    Basic Info
    Product Name:

    Sancycline

    Other Name:

    2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,[4S-(4α,4aα,5aα,12aα)]-;(4S,4aS,5aR,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;GS 2147;Bonomycin;6-Demethyl-6-deoxytetracycline;4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;Sancycline;Norcycline

    CAS No.:

    808-26-4

    Molecular Formula:

    C21H22N2O7

    InChIKeys:

    InChIKey=XDVCLKFLRAWGIT-ADOAZJKMSA-N

    Molecular Weight:

    414.414

    Exact Mass:

    414.41

    EC Number:

    617-177-0

    UNII:

    ODN00F2SJG

    DSSTox ID:

    DTXSID5057836

    Characteristics
    PSA:

    161

    XLogP3:

    -0.67

    Density:

    1.6±0.1 g/cm3

    Melting Point:

    208 °C (decomp)

    Boiling Point:

    750.9±60.0 °C at 760 mmHg

    Flash Point:

    407.9±32.9 °C

    Refractive Index:

    1.735

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Additional category for effects on or via lactation

    GHS label elements, including precautionary statements

    Pictogram(s) No symbol.
    Signal word

    No signal word

    Hazard statement(s)

    H362 May cause harm to breast-fed children

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P263 Avoid contact during pregnancy and while nursing.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

    Location:

    2F Building 10, Zhuhai International Health Port, 628 Airport West Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, China 519090

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2012

    Certifications:

    CERTIFICATE OF REGISTRATION

    NewRoute Pharmaceutical Technology Co., Ltd

    NewRoute Pharma  located in Zhuhai, Guangdon Province, is an innovation-oriented enterprise who engages in R&D, production and sales of API, intermediates, formulations and impurity standards.

    Since its establishment in 2012 , the company has maintained a leading momentum in the field of new drug development . Specialized in new drug technology development and achievement transfer , our company is capable of providing other enterprises with various new drug R&D , production and supporting services , which is the reason for many pharmaceutical enterprises to establish strategic cooperation with us .

  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Sancycline

    100.00 G Feb 9, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.